Elsevier logo

Publisher: Elsevier

Volume 56, Number 9, September 1995
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Oral bisphosphonates in the treatment of osteoporosis: a review
pp. 831-851(21)
Author: Francis R.M.

Intravenous ampicillin/sulbactam versus cefuroxime axetil in the treatment of patients hospitalized with community-acquired lower respiratory tract infections
pp. 852-862(11)
Authors: Rossoff L.J.; Hilton E.; Smith C.; Isenberg H.D.; McKeon Simme M.

Cilazapril in arterial hypertension: effect on the trough-to-peak ratio and on ambulatory blood pressure recorded in an office setting
pp. 863-872(10)
Authors: Leeman M.; Van De Borne P.; Lanoy M.; Haazen L.; Degaute J.-P.

Inhibition of bacterial regrowth in the puerperal uterine cavity of flomoxef
pp. 873-878(6)
Authors: Mikamo H.; Kawazoe K.; Izumi K.; Bandoh K.; Katoh N.; Watanabe K.; Ueno K.; Tamaya T.

Low-dose cyclosporine in the treatment of patients with psoriasis: experience in Hong Kong
pp. 879-886(8)
Authors: Chong L.-Y.; Look C.-N.; Fung C.-W.; Ho K.-M.

Effect of omeprazole and lansoprazole on serum pepsinogen A levels in patients with duodenal ulcer
pp. 887-893(7)
Authors: Chang F.-Y.; Lee C.-T.; Chiang C.-Y.; Lee S.-D.

Lysine clonixinate versus aspirin in the treatment of gonarthrosis
pp. 894-905(12)
Authors: Cayetti L.M.; De Los Santos A.R.; Marti M.L.; Di Girolamo G.; Niselman V.

Doppler-ultrasound pilot study of the effects of long-term policosanol therapy on carotid-vertebral atherosclerosis
pp. 906-914(9)
Authors: Batista J.; Stusser R.; Penichet M.; Uguet E.

Five-day azithromycin in the treatment of patients with community-acquired pneumonia
pp. 915-925(11)
Authors: Hopkins S.; Williams D.

Trials in special populations - Editorial comment
pp. 927-927(1)
Author: Walson P.D.

Chloroquine phosphate suppositories in the treatment of childhood malaria in Calabar, Nigeria
pp. 928-935(8)
Authors: Antia-Obong O.E.; Alaribe A.A.A.; Young M.U.; Bassey A.; Etim B.V.

Introduction
pp. 938-939(2)
Author: Ayuso-Gutierrez J.

The need for extended-release medications
pp. 940-946(7)
Author: Alexander P.E.

Clinical pharmacokinetics of alprazolam extended release: a summary
pp. 947-956(10)
Author: Wright C.E.

Alprazolam extended release in the management of anxiety
pp. 957-965(9)
Author: Figueira M.L.

Once-a-day control of panic disorder: evidence from a placebo-controlled trial of alprazolam extended release
pp. 966-968(3)
Author: Schweizer E.

Discontinuation of benzodiazepines in patients with anxiety disorders: a focus on alprazolam and alprazolam extended release
pp. 969-974(6)
Author: Klein E.

Practical considerations in the use of alprazolam XR
pp. 975-980(6)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A